Tonix (TNXP) CEO Seth Lederman Buys 2,000 Shares

What Happened
Seth Lederman, CEO of Tonix Pharmaceuticals (TNXP), reported an open-market purchase of 2,000 shares on August 27, 2026. The shares were acquired at $13.79 per share for a total cost of $27,580. This was a purchase (insider buy), which investors often view as a modest positive signal but does not by itself prove future performance.

Key Details

• Transaction date: 2026-08-27; reported on Form 4 filed 2026-08-31 (Accession: 0001493152-26-040736) — filing appears timely.
• Transaction type/code: Open market purchase (Code P).
• Price and value: 2,000 shares at $13.79 per share; total $27,580.
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: F1 — reporting person may be deemed a control person of this entity.

Context
This was a straightforward open-market purchase by the CEO (not an option exercise or award). Insider purchases can be more informative than sales, but this is a relatively small-dollar transaction for a CEO and should be considered alongside other filings and company news. No 10b5-1 plan, tax withholding, or other special conditions were disclosed in the filing.